Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by J. D. Leverson
Expression Profile of BCL-2, BCL-XL, and McL-1 Predicts Pharmacological Response to the BCL-2 Selective Antagonist Venetoclax in Multiple Myeloma Models
Molecular Cancer Therapeutics
Cancer Research
Oncology
Related publications
Expression of Beclin-1, BCL-2, BCL-xL, Bad, and Bax in HCV Patients in Relation to Grade of Hepatic Fibrosis
Archives of Infectious Diseases & Therapy
Loss in McL-1 Function Sensitizes Non-Hodgkin’s Lymphoma Cell Lines to the BCL-2-selective Inhibitor Venetoclax (ABT-199)
Blood Cancer Journal
Oncology
Hematology
ABT-737, a Small Molecule BCL-2/BCL-xL Antagonist, Increases Antimitotic-Mediated Apoptosis in Human Prostate Cancer Cells
PeerJ
Genetics
Molecular Biology
Biochemistry
Biological Sciences
Medicine
Agricultural
Neuroscience
BCL-2 Expression Predicts Radiotherapy Failure in Laryngeal Cancer
British Journal of Cancer
Cancer Research
Oncology
Combined Inhibition of Notch Signaling and BCL-2/BCL-xL Results in Synergistic Antimyeloma Effect
Molecular Cancer Therapeutics
Cancer Research
Oncology
The BCL-2 Proteins Noxa and BCL-xL Co-Ordinately Regulate Oxidative Stress-Induced Apoptosis
Biochemical Journal
Biochemistry
Cell Biology
Molecular Biology
Different Expression Patterns of BCL-2, BCL-Xl, and Bax Proteins After Sublethal Forebrain Ischemia in C57Black/Crj6 Mouse Striatum
Stroke
Cardiology
Neurology
Cardiovascular Medicine
Advanced
Medicine
Neuroscience
Specialized Nursing
The Effects of Thymoquinone on Viability, and Anti-Apoptotic Factors (BCL-XL, BCL-2, McL-1) in Prostate Cancer (PC3) Cells: An in Vitro and Computer-Simulated Environment Study
Advanced Pharmaceutical Bulletin
Toxicology
Pharmaceutics
Pharmacology
Pharmaceutical Science
Structure-Based Design of Potent BCL-2/BCL-xL Inhibitors With Strong in Vivo Antitumor Activity
Journal of Medicinal Chemistry
Drug Discovery
Molecular Medicine
